OPKO Health, Inc. is a company in the U.S. stock market and it is a holding in 44 U.S.-traded ETFs. OPK has around 60.5M shares in the U.S. ETF market. The largest ETF holder of OPK is the SPDR S&P Biotech ETF (XBI), with approximately 23.26M shares. Investors may also find of interest that the ETF with the largest allocation to OPK stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 6.94%. On average, U.S. ETFs allocate 0.49% of OPK to their portfolios.
Additionally, OPK is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with OPK as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 50.24%.